Descartes 466 Int. A, Col. Villa Universidad, C.P. 80010 Culiacán, Sinaloa, México
+52 (667) 753-1584


Culiacán, Sin. México, DF.

Ozone treatment reduces markers of oxidative and edothelial damage in an experimental diabetes model in rats

Título
Ozone treatment reduces markers of oxidative and edothelial damage in an experimental diabetes model in rats
Autores

SAID MOHAMMED AL-DALAINa, GREGORIO MARTÍNEZa, EDUARDO CANDELARIO-JALILa,
SILVIA MENÉNDEZb, LAMBERTO REc, ATTILIA GIULIANId and OLGA SONIA LEÓNa

aCenter for Research and Biological Evaluation (CIEB-IFAL), University of Havana, Havana 10400,
Cuba, bOzone Research Center, Cuba, cUniversity of Ancona, Italy, dDepartment of Chemistry and
Medical Biochemistry, University of Milan, Via Saldini, 50-20133 Milan, Italy

Revista o sitio electrónico (URL) donde se publicó

Pharmacological Research, Vol. 44, No. 5, 2001. doi:10.1006/phrs.2001.0867, available online at http://www.idealibrary.com on

Fecha de Publicación

2001-07-17

Abstract

Ozone has been used as a therapeutical agent and beneficial effects have been observed. However so far only a few biochemical and pharmacodynamic mechanisms have been elucidated. We demonstrate that controlled ozone administration may promote an oxidative preconditioning or adaptation to oxidative stress, preventing the damage induced by reactive oxygen species (ROS).
Taking into account that diabetes is a disorder associated with oxidative stress, we postulate that ozone treatment in our experimental conditions might protect antioxidant systems and maintain, at a physiological level, other markers of endothelial cell damage associated with diabetic complications. Five groups of rats were classified as follows: (1) control group treated only with
physiological saline solution; (2) positive control group using streptozotocin (STZ) as a diabetes inductor; (3) ozone group, receiving 10 treatments (1.1 mg kg��1), one per day after STZ-induced diabetes; (4) oxygen group (26 mg kg��1), one per day, as in group 3 but using oxygen only; (5) control ozone group, as group 3, but without STZ. The ozone treatment improved glycemic control and prevented oxidative stress, the increase of aldose reductase, fructolysine content and advanced oxidation protein products. Nitrite and nitrate levels were maintained without changes with regard to non-diabetic control. The results of this study show that repeated administration of ozone in non-toxic doses might play a role in the control of diabetes and its complications.

Regresar

Leave a reply